R&D Advances in immunosuppression research may bring transplant ... There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years.
Partner Content Partner Content Only four weeks till SMi’s 3D Cell Culture Conference 2019 Only four weeks till SMi’s 3D Cell Culture
News Ex-BioNTech execs launch 'AI-native' cancer company Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
